Is a complete MLTX research report available?

No complete published report is available for MoonLake Immunotherapeutics (MLTX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

MoonLake Immunotherapeutics (MLTX)

NASDAQ: MLTX · USD

$19.0

+0.61 (+3.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first MLTX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.6B
Net income (ttm)	-257.1M
EPS (ttm)	-$3.87
Shares out	82.6M
Volume	676,759
Beta	1.04
Price target	$28.0	+47.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -257.1M
EPS (ttm): -$3.87
Market cap: 1.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All MLTX indicators

Market & fundamental data

Available fields

186

Groups with data

Currency

USD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001821586
Company name	MoonLake Immunotherapeutics
Country	Switzerland
Country code	US
Cusip	61559X104
Employees	130
Employees Change	30%
Employees Change Percent	30
Enterprise value	$1.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	KY61559X1045
Last refreshed	2026-07-31
Market cap	$1.6B
Market cap category	Small-Cap
Price	$18.99
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	MLTX
Tags	pharmaceuticals
Website	https://www.moonlaketx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.39%
EV Sales Forward	15,690.77x
FCF yield	-14.29%
P/B ratio	5.39x
PS Forward	18,766.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-257.1M
Net Income Growth Years	0%
Profit Per Employee	$-2M
ROA	-36.66
ROCE	-75.47
ROE	-77.85
ROIC	-39.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-63.75%
Cagr3y	-32.32%
Cagr5y	13.73%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$400.4M
Cash	$357.9M
Current Assets	$396.6M
Current Liabilities	$46.1M
Debt	$100.8M
Debt Equity	$0.4
Equity	$254M
Interest Coverage	-28.15
Liabilities	$146.4M
Long Term Assets	$3.7M
Long Term Liabilities	$100.2M
Net Cash	$257.1M
Net Cash By Market Cap	$16.39
Net Cash Growth	-36.44%
Net Debt Equity	$-1.01
Tangible Book Value	$254M
Tangible Book Value Per Share	$3.52
WACC	9.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.6
Net Working Capital	$-6.5M
Quick ratio	7.89
Working Capital	$350.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.48%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-63.72%
200-day SMA	16.13
3Y total return	-69%
50-day SMA	19.03
50-day SMA vs 200-day SMA	50over200
5Y total return	90.28%
All Time High	64.98
All Time High Change	-70.78%
All Time High Date	2024-02-12
All Time Low	4.25
All Time Low Change	346.82%
All Time Low Date	2022-05-16
ATR	1.03
Beta	1.04
Beta1y	0.3
Beta2y	0.78
Ch YTD	44.08
High	19.09
High52	62.75
High52 Date	2025-09-26
High52ch	-69.74%
Low	18.3
Low52	5.95
Low52 Date	2025-09-29
Low52ch	219.16%
Ma50ch	-0.22%
Premarket Change Percent	0.82
Premarket Price	$18.53
Premarket Volume	7,887
Price vs 200-day SMA	17.72%
RSI	48.42
RSI Monthly	42.34
RSI Weekly	48.89
Sharpe ratio	0.52x
Sortino ratio	0.66
Total Return	-5.48%
Tr YTD	44.08
Tr1m	-4.62%
Tr1w	-1.91%
Tr3m	17.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	15
Analyst Count Top	9
Analyst Price Target Top	$33.38
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.9
Operating Income	$-267.4M
Price target	$28
Price Target Change	$47.45
Price Target Change Top	$75.78

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49,085,749%
Float Percent	59.41%
Net Borrowing	24,467,000
Shares Insiders	8.04%
Shares Institutions	45.95%
Shares Out	82,615,396
Shares Qo Q	4.86%
Shares Yo Y	5.48%
Short Float	12.91%
Short Ratio	4.07
Short Shares	7.67

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-248.1M
Adjusted OCF	-248,116,000
Average Volume	1,076,124.3x
Bv Per Share	3.52
CAPEX	$0
Ch1m	-4.62
Ch1w	-1.91
Ch1y	-63.72
Ch3m	17.88
Ch3y	-69
Ch5y	90.28
Ch6m	17.15
Change	3.32%
Change From Open	2.98
Close	18.38
Days Gap	0.33
Depreciation Amortization	3,083,000
Dollar Volume	12,851,653.4
Earnings Date	2026-08-05
Earnings Time	bmo
EBIT	$-267.4M
EBITDA	$-264.3M
EPS	$-3.87
F Score	1
FCF	$-224.2M
FCF EV Yield	-17.09x
FCF Per Share	$-2.71
Financing CF	103,519,000
Fiscal Year End	December
Founded	2,021
Income Tax	$1.1M
Investing CF	146,844,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-25
Ma150	17.48
Ma150ch	8.63%
Ma20	19.37
Ma20ch	-1.94%
Net CF	26,924,000
Next Earnings Date	2026-08-11
Open	18.44
Optionable	Yes
Position In Range	87.34
Post Close	18.99
Postmarket Change Percent	0.16
Postmarket Price	$19.02
Ppne	2,389,000
Pre Close	18.38
Price Date	2026-07-30
Ptbv Ratio	6.18
Relative Volume	0.63x
Share Based Comp	23,963,000
Tr6m	17.15%
Volume	676,759

MoonLake Immunotherapeutics (MLTX)

Coverage state: Market snapshot only — no published research

Generate the first MLTX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · MLTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MLTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on MLTX

Frequently asked questions